Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshihiro Fujimura

Showing results (51-60 of 176) with videos related to

Pageof 18
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 2, 2006
Novel compound heterozygote mutations (H234Q/R1206X) of the ADAMTS13 gene in an adult patient with Upshaw-Schulman syndrome showing predominant episodes of repeated acute renal failureYugo Shibagaki, Masanori Matsumoto, Koichi Kokame, et al.
International Journal of Hematology|September 23, 2020
Stealth thrombosis of brain and kidney in a girl with Upshaw-Schulman syndrome not receiving prophylactic plasma infusionsSaori Tanabe, Yoshihiro Fujimura, Bernhard Lämmle, et al.
Thrombosis and Haemostasis|March 9, 2012
The homozygous p.C1024R- ADAMTS13 gene mutation links to a late-onset phenotype of Upshaw-Schulman syndrome in JapanFumihiro Taguchi, Hideo Yagi, Masanori Matsumoto, et al.
Pediatrics|December 13, 2016
Severe Hemolysis and Pulmonary Hypertension in a Neonate With Upshaw-Schulman SyndromeNobuyuki Tsujii, Isao Shiraishi, Koichi Kokame, et al.
International Journal of Hematology|September 15, 2005
Rituximab provided long-term remission in a patient with refractory relapsing thrombotic thrombocytopenic purpuraSatoru Kosugi, Masanori Matsumoto, Yasushi Ohtani, et al.
International Journal of Hematology|August 21, 2008
Chemotherapy-resistant intravascular lymphoma accompanied by ADAMTS13 inhibitor successfully treated with rituximabMasatoshi Kanno, Shinobu Nakamura, Makoto Kawahara, et al.
Thrombosis Research|October 18, 2017
Highly elevated plasma level of von Willebrand factor accelerates the formation of platelet thrombus under high shear stress in plasma with deficient ADAMTS13 activityHideo Yagi, Naoko Yamaguchi, Yasuaki Shida, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|May 12, 2015
A Unique Case Involving a Female Patient with Upshaw-Schulman Syndrome: Low Titers of Antibodies against ADAMTS13 prior to Pregnancy Disappeared after Successful DeliveryYoshiyuki Ogawa, Masanori Matsumoto, Hisanobu Sadakata, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|May 3, 2002
[Von Willebrand factor-cleaving protease activity in patients of collagen disease with antiphospholipid antibodies]Satoshi Yamazaki, Masashi Taki, Yoko Yasumuro, et al.
Biomedical Reports|September 13, 2017
Decreased activity of plasma ADAMTS13 are related to enhanced cytokinemia and endotoxemia in patients with acute liver failureHiroaki Takaya, Hitoshi Yoshiji, Hideto Kawaratani, et al.
Pageof 18

Showing results (51-60 of 176) with videos related to

Sort By:
Pageof 18
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 2, 2006
Novel compound heterozygote mutations (H234Q/R1206X) of the ADAMTS13 gene in an adult patient with Upshaw-Schulman syndrome showing predominant episodes of repeated acute renal failureYugo Shibagaki, Masanori Matsumoto, Koichi Kokame, et al.
International Journal of Hematology|September 23, 2020
Stealth thrombosis of brain and kidney in a girl with Upshaw-Schulman syndrome not receiving prophylactic plasma infusionsSaori Tanabe, Yoshihiro Fujimura, Bernhard Lämmle, et al.
Thrombosis and Haemostasis|March 9, 2012
The homozygous p.C1024R- ADAMTS13 gene mutation links to a late-onset phenotype of Upshaw-Schulman syndrome in JapanFumihiro Taguchi, Hideo Yagi, Masanori Matsumoto, et al.
Pediatrics|December 13, 2016
Severe Hemolysis and Pulmonary Hypertension in a Neonate With Upshaw-Schulman SyndromeNobuyuki Tsujii, Isao Shiraishi, Koichi Kokame, et al.
International Journal of Hematology|September 15, 2005
Rituximab provided long-term remission in a patient with refractory relapsing thrombotic thrombocytopenic purpuraSatoru Kosugi, Masanori Matsumoto, Yasushi Ohtani, et al.
International Journal of Hematology|August 21, 2008
Chemotherapy-resistant intravascular lymphoma accompanied by ADAMTS13 inhibitor successfully treated with rituximabMasatoshi Kanno, Shinobu Nakamura, Makoto Kawahara, et al.
Thrombosis Research|October 18, 2017
Highly elevated plasma level of von Willebrand factor accelerates the formation of platelet thrombus under high shear stress in plasma with deficient ADAMTS13 activityHideo Yagi, Naoko Yamaguchi, Yasuaki Shida, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|May 12, 2015
A Unique Case Involving a Female Patient with Upshaw-Schulman Syndrome: Low Titers of Antibodies against ADAMTS13 prior to Pregnancy Disappeared after Successful DeliveryYoshiyuki Ogawa, Masanori Matsumoto, Hisanobu Sadakata, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|May 3, 2002
[Von Willebrand factor-cleaving protease activity in patients of collagen disease with antiphospholipid antibodies]Satoshi Yamazaki, Masashi Taki, Yoko Yasumuro, et al.
Biomedical Reports|September 13, 2017
Decreased activity of plasma ADAMTS13 are related to enhanced cytokinemia and endotoxemia in patients with acute liver failureHiroaki Takaya, Hitoshi Yoshiji, Hideto Kawaratani, et al.
Pageof 18